| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6094148 | Gastroenterology | 2015 | 49 Pages |
Abstract
Sofosbuvir and ribavirin combination therapy for 24 weeks is an effective and well-tolerated interferon-free treatment for post-transplantation HCV infection. EudraCT, Number: 2012-002417-19; ClinicalTrials.gov, Number: NCT01687270.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Michael Charlton, Edward Gane, Michael P. Manns, Robert S. Jr., Michael P. Curry, Paul Y. Kwo, Robert J. Fontana, Richard Gilroy, Lewis Teperman, Andrew J. Muir, John G. McHutchison, William T. Symonds, Diana Brainard, Brian Kirby, Hadas Dvory-Sobol,